OCRA Team
Meet Our Team
OCRA is fortunate to have a Board composed of distinguished leaders, a team of talented, caring Staff members, and a renowned Scientific Advisory Committee, who between them have decades of experience fighting ovarian and related gynecologic cancers. Passionate, knowledgeable, and innovative, they are dedicated to improving the lives of those touched by the disease through advancing research, creating imaginative, empathic support programs, encouraging industry collaboration, and fighting legislative battles on Capitol Hill.
Learn About Our Team Members
Never doubt that a small group of thoughtful committed citizens can change the world: indeed, it’s the only thing that ever has.
– Margaret Mead
Related Topics
Mission & Impact
OCRA is dedicated to improving treatments by advancing innovative research, supporting with expertise and empathy those affected by gynecologic cancers to ensure the best possible care and outcomes, raising awareness, and advocating for legislation that tangibly improves patients’ lives.
OCRA Sponsors NCCN Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in February 2026 to reflect NCCN’s release of the 2026 Guidelines for Cervical Cancer Patients. OCRA is a proud sponsor of the 2026 Patient Guidelines for Cervical Cancer, and the 2025 Patient Guidelines for Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful … Continued
Global Ovarian Cancer Research Consortium Awards Inaugural AI Accelerator Grant with Microsoft’s AI for Good Lab
$1 million global research award, plus an additional $1 million in compute support, advances AI-driven efforts to personalize ovarian cancer care The Global Ovarian Cancer Research Consortium today awarded its inaugural AI Accelerator Grant to an international team of researchers to examine whether artificial intelligence (AI) can improve how survival and treatment response are predicted … Continued